N-Ethyl-2-methyl-5-oxo-7-((3-(trifluoromethyl)-1H-pyrazol-1-yl)-methyl)-5H-thiazolo[3,2-a]pyrimidine-3-carboxamide

ID: ALA3797392

Chembl Id: CHEMBL3797392

PubChem CID: 127047277

Max Phase: Preclinical

Molecular Formula: C15H14F3N5O2S

Molecular Weight: 385.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)c1c(C)sc2nc(Cn3ccc(C(F)(F)F)n3)cc(=O)n12

Standard InChI:  InChI=1S/C15H14F3N5O2S/c1-3-19-13(25)12-8(2)26-14-20-9(6-11(24)23(12)14)7-22-5-4-10(21-22)15(16,17)18/h4-6H,3,7H2,1-2H3,(H,19,25)

Standard InChI Key:  IYICRILSRIBTNE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3797392

    ---

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA2 Tclin Glutamate receptor ionotropic, AMPA 2 (847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.37Molecular Weight (Monoisotopic): 385.0820AlogP: 2.08#Rotatable Bonds: 4
Polar Surface Area: 81.29Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.42CX LogP: 1.91CX LogD: 1.91
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.75Np Likeness Score: -2.35

References

1. Volgraf M, Sellers BD, Jiang Y, Wu G, Ly CQ, Villemure E, Pastor RM, Yuen PW, Lu A, Luo X, Liu M, Zhang S, Sun L, Fu Y, Lupardus PJ, Wallweber HJ, Liederer BM, Deshmukh G, Plise E, Tay S, Reynen P, Herrington J, Gustafson A, Liu Y, Dirksen A, Dietz MG, Liu Y, Wang TM, Hanson JE, Hackos D, Scearce-Levie K, Schwarz JB..  (2016)  Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.,  59  (6): [PMID:26919761] [10.1021/acs.jmedchem.5b02010]

Source